Filing Details
- Accession Number:
- 0001140361-15-012691
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-19 17:41:38
- Reporting Period:
- 2015-03-19
- Filing Date:
- 2015-03-19
- Accepted Time:
- 2015-03-19 17:41:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 730272 | Repligen Corp | RGEN | Biological Products, (No Disgnostic Substances) (2836) | 042729386 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1393547 | Howard Benjamin | C/O Repligen Corporation 41 Seyon St, Bldg 1, Ste 100 Waltham MA 02453 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-03-18 | 10,000 | $6.23 | 58,542 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-03-18 | 3,807 | $15.91 | 62,349 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-03-18 | 15,795 | $32.63 | 46,554 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | StockOption (Right to Buy) | Disposition | 2015-03-18 | 10,000 | $0.00 | 10,000 | $6.23 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-03-18 | 3,807 | $0.00 | 3,807 | $15.91 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 20,000 | 2015-02-28 | 2023-02-28 | No | 4 | M | Direct |
| 7,614 | 2024-02-27 | No | 4 | M | Direct |
Footnotes
- 1. This transaction was executed in multiple trades at prices ranging from $32.55 to $32.728. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- 2. 3,807 shares vest and become exercisable on each of the following dates: 2/27/2015, 2/27/2016 and 2/27/2017.
Billionaire Hedge Funds
